Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.
暂无分享,去创建一个
Mike Gough | Peter M Lansdorp | P. Lansdorp | S. Riddell | M. Jensen | Stanley R Riddell | Michael C Jensen | C. Berger | Carolina Berger | M. Gough | Carole Elliott | Carole Elliott
[1] M. Merkenschlager,et al. Chromatin structure and gene regulation in T cell development and function. , 2006, Current opinion in immunology.
[2] L. Picker,et al. Lymphocyte Homing and Homeostasis , 1996, Science.
[3] Leo Lefrançois,et al. Initial T cell frequency dictates memory CD8+ T cell lineage commitment , 2005, Nature Immunology.
[4] C. Yee,et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.
[5] T. Wyss-Coray,et al. Antigen‐presenting human T cells and antigen‐presenting B cells induce a similar cytokine profile in specific T cell clones , 1993, European journal of immunology.
[6] F. Marincola,et al. Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic Melanoma , 2001, Journal of immunotherapy.
[7] D. Srivastava,et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.
[8] S. Riddell,et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. , 1992, Science.
[9] R. Alon,et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.
[10] P. Lansdorp,et al. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry , 1998, Nature Biotechnology.
[11] T. Schumacher,et al. Immunotherapy through TCR gene transfer , 2001, Nature Immunology.
[12] Hans J. Stauss,et al. Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer , 2001, Nature Immunology.
[13] P. Greenberg,et al. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors. , 1980, Journal of immunology.
[14] V. ter meulen,et al. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. , 2003, Blood.
[15] P. Lansdorp,et al. Telomere length measurements in leukocyte subsets by automated multicolor flow‐FISH , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[16] E. Wherry,et al. Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells , 2002, The Journal of experimental medicine.
[17] Andrew J. McMichael,et al. Molecular Signatures Distinguish Human Central Memory from Effector Memory CD8 T Cell Subsets1 , 2005, The Journal of Immunology.
[18] D. Fearon,et al. Arrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination , 2001, Science.
[19] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[20] D. Srivastava,et al. Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients , 1998 .
[21] C. Pitcher,et al. Development and Homeostasis of T Cell Memory in Rhesus Macaque1 , 2002, The Journal of Immunology.
[22] S. Rosenberg,et al. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] P. Deegen,et al. Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting , 2005, Journal of Virology.
[24] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[25] T. Waldmann,et al. The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells , 2007, Proceedings of the National Academy of Sciences.
[26] S. Rosenberg,et al. Telomere Length of Transferred Lymphocytes Correlates with In Vivo Persistence and Tumor Regression in Melanoma Patients Receiving Cell Transfer Therapy1 , 2005, The Journal of Immunology.
[27] S. Larson,et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 , 2003, Nature Medicine.
[28] T. Waldmann,et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Thompson,et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Blattman,et al. Cancer Immunotherapy: A Treatment for the Masses , 2004, Science.
[31] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[32] E. Mocarski,et al. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] E. Wherry,et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.
[34] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[35] Michel Sadelain,et al. Targeting tumours with genetically enhanced T lymphocytes , 2003, Nature Reviews Cancer.
[36] E. Warren,et al. Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation. , 2006, Blood.
[37] Mario Roederer,et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.
[38] L. Lefrançois,et al. The descent of memory T-cell subsets , 2006, Nature Reviews Immunology.
[39] C Haanen,et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.
[40] T. Reynolds,et al. T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.
[41] S. Riddell,et al. Molecules and mechanisms of the graft-versus-leukaemia effect , 2004, Nature Reviews Cancer.
[42] T. Blankenstein,et al. Retroviral vectors for high-level transgene expression in T lymphocytes. , 2003, Human gene therapy.
[43] E John Wherry,et al. The role of programming in memory T-cell development. , 2004, Current opinion in immunology.
[44] Antonio Lanzavecchia,et al. Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.
[45] T. Waldmann,et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Heimfeld,et al. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model. , 2004, Blood.
[47] S. Riddell,et al. Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate Model , 2001, Journal of Virology.
[48] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[49] L. Lefrançois,et al. Cutting Edge: Requirement for IL-15 in the Generation of Primary and Memory Antigen-Specific CD8 T Cells1 , 2002, The Journal of Immunology.
[50] S. Rosenberg,et al. Adoptive immunotherapy for cancer: building on success , 2006, Nature Reviews Immunology.
[51] H. Broxmeyer,et al. Modulation of Hematopoietic Stem Cell Homing and Engraftment by CD26 , 2004, Science.
[52] H. Heslop,et al. Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease , 2004, The Journal of experimental medicine.